N-Boc-L-tert-Leucine|CS-W008945|62965-35-9

N-Boc-L-tert-Leucine

$88.60

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku TS246CS-W008945_1000_G
ChemScene
Get Bulk Quote

Product Information

Product Name
N-Boc-L-tert-Leucine
Brand Name
ChemScene
Product Number
CS-W008945
CAS
62965-35-9
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
2734668
IUPAC Name
(2S)-3,3-dimethyl-2-(2-methylpropan-2-yl)oxycarbonylaminobutanoic acid
InChI Key
LRFZIPCTFBPFLX-SSDOTTSWSA-N
SMILES
CC(C)(C)C@@H(C(=O)O)NC(=O)OC(C)(C)C

References

The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
Publication Name: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Publication Date: 2022-08-30
DOI: 10.1007/s00044-022-02951-6

Correction to: Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
Publication Name: Acta Neuropathologica Communications
Publication Date: 2022-04-22
DOI: 10.1186/s40478-022-01326-7|10.1186/s40478-022-01368-x

An Orally Available Clinical Candidate to Treat Covid-19
Publication Name: Synfacts
Publication Date: 2022-01-18
DOI: 10.1055/s-0041-1737252

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H ActivationC-H activation
Publication Name: Methods in molecular biology (Clifton, N.J.)
Publication Date: 2022
DOI: 10.1007/978-1-0716-1689-5_3

Nirmatrelvir
Publication Name: Pharmaceutical Substances
Publication Date: 2022